RNA therapeutics are becoming increasingly complex through chemical modifications, delivery strategies, and diverse RNA modalities such as mRNA, siRNA, ASOs, and circRNA.
Sponsored by:
insight hubs
Articles
How can researchers navigate the complexity of RNA drug discovery
What are the challenges in antibody drug discovery — and how can they be addressed
Antibody discovery requires optimization across multiple dimensions, including target engagement, functional activity, immunogenicity, and developability.
What drives successful small-molecule drug discovery today
Small-molecule discovery is evolving beyond traditional approaches, with AI, expanded chemical space, and emerging modalities reshaping how candidates are designed and optimized.
Empowering modern research with electronic lab notebooks
Modern research generates more data than ever — across experiments, protocols, teams, and locations. Traditional paper notebooks can make that information difficult to search, secure, share, and reuse.
From Discovery to Delivery: The Rise of New Modalities
In the rapidly evolving landscape of pharmaceuticals and biotechnology, the emergence of multimodal drug discovery heralds a transformative era, where innovation and strategic foresight are paramount.
The New RNA World: Evolving RNA from Messenger to Versatile Therapeutic
RNA has evolved from a molecular messenger into a powerful and versatile therapeutic tool.
The Evolution of Antibody Drug Discovery: Unlocking Innovation with Bioinformatic and AIs
Since monoclonal antibodies (mAbs) were developed and received their first approval, they became indispensable as research tools and biotherapeutic agents.
The Innovation Imperative: Pioneering New Modalities for Therapeutic Leadership
In the rapidly evolving landscape of pharmaceuticals and biotechnology, the emergence of multimodal drug discovery heralds a transformative era for drug discovery, where innovation and strategic Foresight are paramount.
insight hubs
White Papers
Building a unified design-make-test-decide approach to drug discovery
Drug discovery has long followed a core loop: design a molecule, synthesize it, test its biological properties, and analyze the results to inform the next round of design.
Beyond algorithms: Building stronger AI foundations for drug discovery
Modern drug discovery produces more data than ever, from genomics and chemical screening to imaging and patient datasets
New modalities, new tools Choosing a flexible digital platform for drug discovery
As pharmaceutical innovation rapidly evolves, the complexity of data generated from RNA therapeutics, gene therapies, antibody-drug conjugates (ADCs), and protein degraders necessitates a new approach to digital infrastructure.
From Protacs to Dacs : How targeted protein degraders are breaking rules and boundaries in drug design
Advancements in healthcare diagnostics, emphasizing the need for innovative technologies to improve disease detection and patient outcomes.
insight hubs
Guidelines
A scientist’s guide to electronic laboratory notebook selection
Modern drug discovery depends on fast, reliable access to high-quality experimental data. But fragmented systems, manual documentation, and outdated ELNs can leave scientists
A Scientist’s guide to electronic laboratory notebook selection
Modern drug discovery depends on fast, reliable access to high-quality experimental data. Yet many R&D teams still rely on disconnected systems, manual documentation, or outdated ELNs that cannot keep pace with evolving scientific processes.
A Technology Guide to Integrated Informatics for Scientific Research
Contemporary scientific research reflects a growing focus on complexity and collaboration.